The phrase "a study in Kampala" is correct and usable in written English.
It can be used when referring to a research project or academic work conducted in the city of Kampala, Uganda.
Example: "The findings of a study in Kampala revealed significant insights into urban development challenges."
Alternatives: "an analysis in Kampala" or "a research project in Kampala".
A 2005 study in Gabon [ 31] and a 2008-2011 study in Kampala, Uganda [ 32] found that patients who had reported having received treatment from traditional healers or other informal sources had lower CD4 counts at treatment initiation.
In line with a previous study in Kampala, Uganda [ 33], this study shows that a significant proportion of TB patients used alternative healthcare as the first choice of care in Hohoe Municipality, with nearly 40%% initially presenting to pharmacy or drug shops, traditional healers, and private clinic.
A crossectional study in Kampala and Mukono Districts in 2002 estimated the prevalence of type 2 diabetes to be 8% among people aged ≥35 years [ 19].
More recently, a study in Peri-urban Kampala showed resistance to isoniazid of 8.1%, rifampicin resistance of 4.4% and MDR was found to be 4.4% [ 5].
More recently, a study in peri-urban Kampala showed resistance to isoniazid of 8.1%, rifampicin resistance of 4.4% and MDR was found to be 4.4% [ 35].
Based on the prevalence of vitamin D deficiency (defined as vitamin D levels < 20 ng/ml) of 9 % among healthy individuals in a study in Mulago Hospital, Kampala [ 5] with a 95%% CI and desired precision of estimation of 0.05, a sample size of 126 patients was obtained.
More recently a hospital based study in Kampala found 12.7% MDR among previously treated patients [8].
Samples were collected from patients with at least one positive culture for M. tuberculosis who were previously enrolled in the Kawempe Community Household Contact Study, an ongoing epidemiological study in Kampala, Uganda, from which several papers have been published [ 15- 17].
7 9 A prospective parallel cohort study in Kampala, Uganda, also showed an 80% protective efficacy of co-trimoxazole prophylaxis against malaria among HIV infected children compared with HIV uninfected children not taking co-trimoxazole.
